Suppression of intestinal neoplasia by deletion of Dnmt3b.


Aberrant gene silencing accompanied by DNA methylation is associated with neoplastic progression in many tumors that also show global loss of DNA methylation. Using conditional inactivation of de novo methyltransferase Dnmt3b in Apc(Min/+) mice, we demonstrate that the loss of Dnmt3b has no impact on microadenoma formation, which is considered the earliest stage of intestinal tumor formation. Nevertheless, we observed a significant decrease in the formation of macroscopic colonic adenomas. Interestingly, many large adenomas showed regions with Dnmt3b inactivation, indicating that Dnmt3b is required for initial outgrowth of macroscopic adenomas but is not required for their maintenance. These results support a role for Dnmt3b in the transition stage between microadenoma formation and macroscopic colonic tumor growth and further suggest that Dnmt3b, and by extension de novo methylation, is not required for maintaining tumor growth after this transition stage has occurred.

7 Figures and Tables

Citations per Year

362 Citations

Semantic Scholar estimates that this publication has 362 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lin2006SuppressionOI, title={Suppression of intestinal neoplasia by deletion of Dnmt3b.}, author={Haijiang Lin and Yasuhiro Yamada and Suzanne Pham Nguyen and Heinz G. Linhart and Laurie Jackson-Grusby and Alexander Meissner and Konstantinos Meletis and Grace H Lo and Rudolf Jaenisch}, journal={Molecular and cellular biology}, year={2006}, volume={26 8}, pages={2976-83} }